For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Inspire Medical Systems Inc (NYSE: INSP) was $115.51 for the day, down -3.14% from the previous closing price of $119.26. In other words, the price has decreased by -$3.14 from its previous closing price. On the day, 3.19 million shares were traded. INSP stock price reached its highest trading level at $121.19 during the session, while it also had its lowest trading level at $113.03.
Ratios:
Our analysis of INSP’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 33.96. For the most recent quarter (mrq), Quick Ratio is recorded 4.01 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On December 02, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $130.
Truist Upgraded its Hold to Buy on November 26, 2025, while the target price for the stock was maintained at $165.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 02 ’25 when mcCormick Shawn sold 1,200 shares for $139.00 per share. The transaction valued at 166,800 led to the insider holds 24,846 shares of the business.
SHAWN T MCCORMICK bought 1,200 shares of INSP for $151,608 on Dec 02 ’25. On Nov 28 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 2,000 shares for $127.48 each. As a result, the insider received 254,960 and left with 26,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 3416129280 and an Enterprise Value of 3066292736. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 79.22, and their Forward P/E ratio for the next fiscal year is 67.10. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.80 while its Price-to-Book (P/B) ratio in mrq is 5.04. Its current Enterprise Value per Revenue stands at 3.474 whereas that against EBITDA is 62.146.
Stock Price History:
The Beta on a monthly basis for INSP is 0.71, which has changed by -0.36214364 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $216.01, while it has fallen to a 52-week low of $70.77. The 50-Day Moving Average of the stock is 19.05%, while the 200-Day Moving Average is calculated to be -3.61%.
Shares Statistics:
INSP traded an average of 1.36M shares per day over the past three months and 1949080 shares per day over the past ten days. A total of 29.05M shares are outstanding, with a floating share count of 27.75M. Insiders hold about 4.49% of the company’s shares, while institutions hold 104.46% stake in the company. Shares short for INSP as of 1764288000 were 3481719 with a Short Ratio of 2.57, compared to 1761868800 on 3305009. Therefore, it implies a Short% of Shares Outstanding of 3481719 and a Short% of Float of 16.189999999999998.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 12.0 analysts currently analyzing and rating the stock of Inspire Medical Systems Inc (INSP).The consensus estimate for the next quarter is $0.12, with high estimates of $0.31 and low estimates of -$0.22.
Analysts are recommending an EPS of between $1.65 and $0.99 for the fiscal current year, implying an average EPS of $1.55. EPS for the following year is $1.66, with 12.0 analysts recommending between $2.01 and $1.31.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 15 analysts. It ranges from a high estimate of $263.1M to a low estimate of $260M. As of. The current estimate, Inspire Medical Systems Inc’s year-ago sales were $239.72MFor the next quarter, 15 analysts are estimating revenue of $213.4M. There is a high estimate of $223.4M for the next quarter, whereas the lowest estimate is $204.21M.
A total of 17 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $908.29M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $905.04M. In the same quarter a year ago, actual revenue was $802.8MBased on 17 analysts’ estimates, the company’s revenue will be $1B in the next fiscal year. The high estimate is $1.06B and the low estimate is $997.8M.
